BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30662007)

  • 21.
    Lee DH; Park SH; Ahn J; Hong SP; Lee E; Jang YJ; Ha TY; Huh YH; Ha SY; Jeon TI; Jung CH
    Autophagy; 2021 Sep; 17(9):2415-2431. PubMed ID: 33078654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation.
    Li S; Li J; Shen C; Zhang X; Sun S; Cho M; Sun C; Song Z
    Biochim Biophys Acta; 2014 Jan; 1841(1):22-33. PubMed ID: 24055888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway.
    Yan LS; Zhang SF; Luo G; Cheng BC; Zhang C; Wang YW; Qiu XY; Zhou XH; Wang QG; Song XL; Pan SY; Zhang Y
    Metabolism; 2022 Jun; 131():155200. PubMed ID: 35405150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteocalcin activates lipophagy via the ADPN-AMPK/PPARα-mTOR signaling pathway in chicken embryonic hepatocyte.
    Tu WJ; Zhang YH; Wang XT; Zhang M; Jiang KY; Jiang S
    Poult Sci; 2024 Feb; 103(2):103293. PubMed ID: 38070403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK.
    Huang Q; Wang T; Yang L; Wang HY
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease.
    Zhang H; Lu J; Liu H; Guan L; Xu S; Wang Z; Qiu Y; Liu H; Peng L; Men X
    Pharmacol Res; 2021 Dec; 174():105964. PubMed ID: 34732369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces liver lipid metabolism disorder via the ROS/AMPK/CD36 signaling pathway.
    Cong Y; Hong Y; Wang D; Cheng P; Wang Z; Xing C; Sun W; Xu G
    Toxicol Sci; 2023 Feb; 191(2):276-284. PubMed ID: 36534932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Mammalian Target of Rapamycin-Perilipin 3 (mTORC1-Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis.
    Garcia-Macia M; Santos-Ledo A; Leslie J; Paish HL; Collins AL; Scott RS; Watson A; Burgoyne RA; White S; French J; Hammond J; Borthwick LA; Mann J; Bolaños JP; Korolchuk VI; Oakley F; Mann DA
    Hepatology; 2021 Dec; 74(6):3441-3459. PubMed ID: 34233024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dihydromyricetin reduces lipid accumulation in LO2 cells
    Liao X; Hao Y; Wu M; Liu H; Jiang L; Ye Z; Liao W; Deng H
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):518-527. PubMed ID: 35527487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
    Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
    Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dengue Virus Activates the AMP Kinase-mTOR Axis To Stimulate a Proviral Lipophagy.
    Jordan TX; Randall G
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice.
    Liu TY; Xiong XQ; Ren XS; Zhao MX; Shi CX; Wang JJ; Zhou YB; Zhang F; Han Y; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
    Diabetes; 2016 Nov; 65(11):3262-3275. PubMed ID: 27504012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice.
    Yao L; Wang C; Zhang X; Peng L; Liu W; Zhang X; Liu Y; He J; Jiang C; Ai D; Zhu Y
    Hepatology; 2016 Jul; 64(1):92-105. PubMed ID: 26928949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing.
    Zeng H; Qin H; Liao M; Zheng E; Luo X; Xiao A; Li Y; Chen L; Wei L; Zhao L; Ruan XZ; Yang P; Chen Y
    Mol Metab; 2022 Mar; 57():101428. PubMed ID: 34974159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [KLF9 regulates hepatic lipid metabolism via inducing CD36 expression].
    Zhou SS; Zhang YL; Chang YS
    Sheng Li Xue Bao; 2021 Oct; 73(5):772-780. PubMed ID: 34708234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice.
    Yang P; Xiao Y; Luo X; Zhao Y; Zhao L; Wang Y; Wu T; Wei L; Chen Y
    J Lipid Res; 2017 Jul; 58(7):1417-1427. PubMed ID: 28536108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.
    Kim SH; Kim G; Han DH; Lee M; Kim I; Kim B; Kim KH; Song YM; Yoo JE; Wang HJ; Bae SH; Lee YH; Lee BW; Kang ES; Cha BS; Lee MS
    Autophagy; 2017 Oct; 13(10):1767-1781. PubMed ID: 28933629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor.
    Hoang-Yen Tran D; Hoang-Ngoc Tran D; Mattai SA; Sallam T; Ortiz C; Lee EC; Robbins L; Ho S; Lee JE; Fisseha E; Shieh C; Sideri A; Shih DQ; Fleshner P; McGovern DP; Vu M; Hing TC; Bakirtzi K; Cheng M; Su B; Law I; Karagiannides I; Targan SR; Gallo RL; Li Z; Koon HW
    Int J Obes (Lond); 2016 Sep; 40(9):1424-34. PubMed ID: 27163748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of AMPK activation by CD36 links fatty acid uptake to β-oxidation.
    Samovski D; Sun J; Pietka T; Gross RW; Eckel RH; Su X; Stahl PD; Abumrad NA
    Diabetes; 2015 Feb; 64(2):353-9. PubMed ID: 25157091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes.
    Negoita F; Blomdahl J; Wasserstrom S; Winberg ME; Osmark P; Larsson S; Stenkula KG; Ekstedt M; Kechagias S; Holm C; Jones HA
    J Cell Biochem; 2019 Jan; 120(1):343-356. PubMed ID: 30171718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.